Riverside Medical Clinic’s Clinical Research department and Ongoing Research Trials are dedicated to our community with access to cutting-edge medical treatments. By working with pharmaceutical and biotechnology companies, we take part in the latest treatments being developed for the U.S. market.
We specialize in trials in the following areas:
|Infectious Diseases||Chronic Pain||Skin Disorders|
|Migraine Headaches||& More…|
Patient safety and welfare is our first priority. All trials conducted at our clinic are FDA monitored and overseen by an Institutional Review Board. Our dedicated team of physicians and staff work together to ensure patient safety and integrity of study data throughout the entire process.
Astra Zeneca: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients with Severe Asthma Uncontrolled on Standard of Care Treatment (ANDHI).
Abbott: The study is to evaluate the long term safety of the FDA approved St. Jude Medical Tendril MRI™, Endurity MRI™, or similar model in subjects with a standard bradycardia pacing indication. Additionally, the study will look at how the SJM Brady MRI system works after it has undergone an MRI scan.
The new project with Quidel Corp. is a device study “Sofia 2 SARS and FluA+B and SARS Validation Study” in developing a new test for assisting in diagnosing COVID-19 infections. Nasal swabs will be collected for those patients who have symptoms of COVID-19 and to those of whom the treating doctor suspects they may have COVID-19.
Please contact the Clinical Research Department for Enrolling and Ongoing Research Trials to see if you qualify at (951) 321-6473
Be a part of the solution and begin your new treatment option with the medicine of tomorrow!